BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Suppression of molecular inflammatory pathways by Toll-like Receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation

Dataset: Suppression of molecular inflammatory pathways by Toll-like Receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation

Psoriasis is a complex inflammatory disease resulting from the activation of T helper (Th) 1 and Th17 cells. Recent evidence suggests...

Registered by ArrayExpress Uploader
View Dataset

Psoriasis is a complex inflammatory disease resulting from the activation of T helper (Th) 1 and Th17 cells. Recent evidence suggests that abnormal activation of Toll-like receptors (TLRs) 7, 8 and 9 contributes to the initiation and maintenance of psoriasis. We have evaluated the effects of TLR antagonists on the gene expression profile in an IL-23-induced skin inflammation model in mice. Psoriasis-like skin lesions were induced in C57BL/6 mice by intradermal injection of IL-23 in the dorsum. Two TLR antagonists were compared: IMO-3100, an antagonist of TLRs 7 and 9, and IMO-8400, an antagonist of TLRs 7, 8 and 9, both of which previously have been shown to reduce epidermal hyperplasia in this model. Skin gene expression profiles of IL-23-induced inflammation were compared with or without TLR antagonist treatment. IL-23 injection resulted in alteration of 5100 gene probes (fold change ≥ 2, FDR < 0.05) including IL-17 pathways that are up-regulated in psoriasis vulgaris. Targeting TLRs 7, 8 and 9 with IMO-8400 resulted in modulation of more than 2300 mRNAs while targeting TLRs 7 and 9 with IMO-3100 resulted in modulation of more than 1900 mRNAs. Both agents strongly decreased IL-17A expression (>12-fold reduction), normalized IL-17 induced genes such as beta-defensin and CXCL1, and normalized aberrant expression of keratin 16 (indicating epidermal hyperplasia). These results suggest that IL-23-driven inflammation in mouse skin may be dependent on signaling mediated by TLRs 7, 8, and 9 and that these receptors represent novel therapeutic targets in psoriasis vulgaris and other diseases with similar pathophysiology. Expression profiles for mice with IL23-induced phenotype (psoriasisform) at baseline and after treatment with two doses of TLR7/8/9 antagonist and saline. Samples for nomal mice are also available

Species:
mouse

Samples:
20

Source:
E-GEOD-50400

PubMed:
24386404

Updated:
Dec.12, 2014

Registered:
Nov.12, 2014


Factors: (via ArrayExpress)
Sample TREATMENT CONDITION
GSM1218155 IMO-8400 IL23 induced phenotype
GSM1218155 IMO-8400 IL23 induced phenotype
GSM1218155 IMO-8400 IL23 induced phenotype
GSM1218155 IMO-8400 IL23 induced phenotype
GSM1218155 IMO-8400 IL23 induced phenotype
GSM1218160 IMO-3100 IL23 induced phenotype
GSM1218160 IMO-3100 IL23 induced phenotype
GSM1218160 IMO-3100 IL23 induced phenotype
GSM1218160 IMO-3100 IL23 induced phenotype
GSM1218160 IMO-3100 IL23 induced phenotype
GSM1218165 saline IL23 induced phenotype
GSM1218165 saline IL23 induced phenotype
GSM1218165 saline IL23 induced phenotype
GSM1218165 saline IL23 induced phenotype
GSM1218165 saline IL23 induced phenotype
GSM1218170 na�ve normal
GSM1218170 na�ve normal
GSM1218170 na�ve normal
GSM1218170 na�ve normal
GSM1218170 na�ve normal

Tags

  • disease
  • keratin
  • psoriasis
  • skin

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2023 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use